Medicina
Departamento
Hospital Universitario Reina Sofia
Córdoba, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Reina Sofia (32)
2024
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
2022
-
Carbohydrate antigen 125 (CA125) as a prognostic marker in the elderly with acute heart failure and preserved ejection fraction
Medicina Clinica, Vol. 159, Núm. 4, pp. 164-170
-
Morbidity and mortality in elderly patients with heart failure managed with a comprehensive care model vs. usual care: The UMIPIC program
Revista Clinica Espanola, Vol. 222, Núm. 3, pp. 123-130
2021
-
Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?
International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260
-
Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ros study
Cancers, Vol. 13, Núm. 18
-
Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 283.e9-283.e16
-
Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study)
International Journal of Antimicrobial Agents, Vol. 58, Núm. 1
2020
-
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: The NEW_SAFE project
BMJ Open, Vol. 10, Núm. 7
-
Randomized study to evaluate the impact of telemedicine care in patients with type 1 diabetes with multiple doses of insulin and suboptimal HbA1c in Andalusia (Spain): PLATEDIAN study
Diabetes Care, Vol. 43, Núm. 2, pp. 337-342
2019
-
Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients
HIV Medicine, Vol. 20, Núm. 6, pp. 359-367
2018
-
Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 20, Núm. 1
-
Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation
Seminars in Hematology, Vol. 55, Núm. 4, pp. 189-196
2017
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
-
Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 19, Núm. 1
-
Prognostic implication of early ventricular fibrillation among patients with ST elevation myocardial infarction
Coronary Artery Disease, Vol. 28, Núm. 7, pp. 570-576
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and risk factors for esophagitis in Spain: A cross-sectional study)
United European Gastroenterology Journal, Vol. 4, Núm. 2, pp. 229-235
2015
-
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174
2014
-
Predictors of early mortality in very elderly patients with bacteremia: A prospective multicenter cohort
International Journal of Infectious Diseases, Vol. 26, pp. 83-87
2013
-
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy
Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326